Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II
- 1 February 2015
- journal article
- clinical trial
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 114 (2) , 170-177
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS I and IIMolecular Genetics and Metabolism, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Recognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome)Pediatrics, 2008
- Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapyEuropean Journal of Pediatrics, 2007
- Intrathecal enzyme replacement therapy: Successful treatment of brain disease via the cerebrospinal fluidMolecular Genetics and Metabolism, 2007
- Correlation between cerebral MRI abnormalities and mental retardation in patients with mucopolysaccharidosesAmerican Journal of Medical Genetics Part A, 2003
- Whole Brain SegmentationNeuron, 2002
- Hopkins Verbal Learning Test – Revised: Normative Data and Analysis of Inter-Form and Test-Retest ReliabilityThe Clinical Neuropsychologist, 1998
- THE NATURAL HISTORY OF THE SEVERE FORM OF HUNTER'S SYNDROME: A STUDY BASED ON 52 CASESDevelopmental Medicine & Child Neurology, 1983
- Mild form of Hunter's syndrome: clinical delineation based on 31 cases.Archives of Disease in Childhood, 1982